(NASDAQ:SLN) LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in the following conferences: Morgan Stanley Global Healthcare Conference Fireside Chat on Tuesday, September 9, 2025 at 5:35 p.m. ET H.C. Wainwright Global Investment Conference Fireside Chat on Wednesday, September 10, 2025 at 12:00 p.m. ET The webcasts can be acce